Evidence‐based interventions to improve patient compliance with antihypertensive and lipid‐lowering medications
AA Petrilla, JS Benner, DS Battleman… - … journal of clinical …, 2005 - Wiley Online Library
The MEDLINE database was searched from 1972 to June 2002 to identify studies of interventions
designed to improve compliance with antihypertensive or lipid‐lowering medications. …
designed to improve compliance with antihypertensive or lipid‐lowering medications. …
Predictors of adherence with antihypertensive and lipid-lowering therapy
…, JC Tierce, SR Collins, DS Battleman… - Archives of internal …, 2005 - jamanetwork.com
… D Adherence to chronic therapy among patients treated for hypertension, dyslipidemia, or …
D Adherence to chronic therapy among patients treated for hypertension, dyslipidemia, or both …
D Adherence to chronic therapy among patients treated for hypertension, dyslipidemia, or both …
Mechanism of repetitive monomorphic ventricular tachycardia
…, DS Battleman, N Lippman, D Bei, D Catanzaro - Circulation, 1995 - Am Heart Assoc
Background The most common form of idiopathic ventricular tachycardia (VT) is repetitive
monomorphic VT (RMVT), which is characterized by frequent ventricular ectopy and salvos of …
monomorphic VT (RMVT), which is characterized by frequent ventricular ectopy and salvos of …
Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of …
DS Battleman, M Callahan… - Archives of Internal …, 2002 - jamanetwork.com
Objectives To measure quality-of-care variables relevant to the treatment of community-acquired
pneumonia and to determine their relative contribution to variation in length of hospital …
pneumonia and to determine their relative contribution to variation in length of hospital …
[PDF][PDF] Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease
ML Johnson, K Pietz, DS Battleman, RJ Beyth - Heart Dis, 2004 - ajmc.s3.amazonaws.com
Study Design A retrospective design was used to collect data longitudinally during 3 years.
The prevalence of hypertension, dyslipidemia, and diabetes mellitus was estimated by …
The prevalence of hypertension, dyslipidemia, and diabetes mellitus was estimated by …
Cost of atrial fibrillation in United States managed care organizations
Introduction Atrial fibrillation (AF) has been shown to be associated with high healthcare
costs; however, limited data are available from large-scale studies quantifying the overall cost …
costs; however, limited data are available from large-scale studies quantifying the overall cost …
Rates of venous thromboembolism occurrence in medical patients among the insured population
…, M Hussein, J Lin, D Battleman - Thrombosis and …, 2009 - thieme-connect.com
The burden of venous thromboembolism (VTE) remains high in the United States (US). This
study assesses the rate of VTE prophylaxis in a large real-world population of medically ill …
study assesses the rate of VTE prophylaxis in a large real-world population of medically ill …
Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database study
…, M Hussein, J Lin, D Battleman - Journal of thrombosis and …, 2009 - Springer
US national performance measures may reduce the burden of venous thromboembolism (VTE)
in surgical patients. To characterize the VTE rate in US surgical patients, and identify real-…
in surgical patients. To characterize the VTE rate in US surgical patients, and identify real-…
Reduction in angioplasty complications after the introduction of coronary stents: results from a consecutive series of 2242 patients
DB Altmann, M Racz, DS Battleman, G Bergman… - American heart …, 1996 - Elsevier
… Herrmann HC, Malosky SA, Guidera SA, DeA~gelo D, Hirshfe]d JW. Patient selection reduces
thrombotic complications of emergent stenting for failed PTCA. Cathet Cardiovasc Diagu …
thrombotic complications of emergent stenting for failed PTCA. Cathet Cardiovasc Diagu …
Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series.
…, A LeBlanc, IB Walters, DS Battleman - Clinical advances in …, 2008 - europepmc.org
Bortezomib therapy has become an important part of the standard of care for patients with
relapsed multiple myeloma, and preliminary clinical evidence suggests that bortezomib …
relapsed multiple myeloma, and preliminary clinical evidence suggests that bortezomib …